Status:

UNKNOWN

Optimising Secondary Prevention and Quality of Life in Early Cardiac Rehabilitation

Lead Sponsor:

Sheffield Hallam University

Collaborating Sponsors:

AstraZeneca

Sheffield Teaching Hospitals NHS Foundation Trust

Conditions:

Cardiovascular Diseases

Coronary Artery Disease

Eligibility:

All Genders

18+ years

Brief Summary

The primary aim of this research is to explore the adherence and drop-out from early cardiac rehabilitation (CR), to inform interventions to support patient's adherence to CR and facilitate maintenanc...

Detailed Description

This study will explore the attitudes of patients and healthcare practitioners towards the components of CR (diet, smoking, and medication) and their relationship with improving patients' perceived he...

Eligibility Criteria

Inclusion

  • Inclusion criteria patients:
  • Patients who fall within the National Audit of CR (NACR) priority groups. These include Myocardial Infarction (MI), MI + Percutaneous Coronary Intervention (PCI), PCI, Coronary Artery Bypass Graft (CAGB), and Heart Failure.
  • Aged over 18 years (i.e., all adults).
  • No evidence of cognitive impairment which will limit the ability to follow basic instructions.
  • Inclusion criteria professionals:
  • Those who have a key responsibility for delivering or managing CR at one of the six local sites, including - healthcare professionals and/or CR providers.
  • Exclusion criteria patients:
  • Patients who fall outside of the NACR priority groups.
  • Aged under 18 years (i.e., all adults).
  • Evidence of cognitive impairment which will limit the ability to follow basic instructions (Participants unable to give informed consent).
  • Exclusion criteria professionals:
  • Trainee or administrative staff members.
  • Staff members with less than four months of experience working in CR.

Exclusion

    Key Trial Info

    Start Date :

    March 19 2021

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ESTIMATED

    End Date :

    September 1 2022

    Estimated Enrollment :

    498 Patients enrolled

    Trial Details

    Trial ID

    NCT04781699

    Start Date

    March 19 2021

    End Date

    September 1 2022

    Last Update

    November 8 2021

    Active Locations (6)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 2 (6 locations)

    1

    Northumbria Healthcare NHS Foundation Trust

    Newcastle upon Tyne, Blyth, United Kingdom, NE24 1DX

    2

    Aneurin Bevan University Health Board

    Ystrad Mynach, Gwent, United Kingdom, CF82 7GP

    3

    Royal Brompton Hospital

    London, Harefield Middlesex, United Kingdom, UB9 6JH

    4

    Sheffield Teaching Hospitals

    Sheffield, South Yorkshire, United Kingdom, S5 7AU